Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force
Jan M. Friedman(University of British Columbia), Bruce R. Korf(Harvard University), Stephen J. Huot(Yale University), Jonathan A. Epstein(California Institute for Regenerative Medicine), Bruce M. McManus(University of British Columbia), Jack L. Arbiser(Emory University), David H. Gutmann(Washington University in St. Louis), Angela E. Lin(Massachusetts General Hospital)
Cited by 398
Related Papers
Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
|European Journal of Endocrinology|2017|1.1k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
Targeting cardiac fibrosis with engineered T cells
|Nature|2019|792
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766